Does the FDA think these data justify full approval of Covid Vaxx?

Does the FDA think these data justify full approval of Covid Vaxx?

Prior to the preprint, my view, along with a group of around 30 clinicians, scientists, and patient advocates, was that there were simply too many open questions about all covid-19 vaccines to support approving any this year. The preprint has, unfortunately, addressed very few of those open questions, and has raised some new ones.

Unfortunately, it was just given full approval by the FDA.

Advertisement

The FDA just fully approved Pfizer’s COVID-19 vaccine in a move that could lead to more vaccinations

The FDA just fully approved Pfizer’s COVID-19 vaccine in a move that could lead to more vaccinations

The shift to full approval could persuade some vaccine-hesitant people in the US to get the shot. A common talking point among skeptics of the COVID-19 shots has been that they’re not fully approved and are technically experimental medicines under emergency OKs. Pfizer’s vaccine winning standard approval directly addresses that concern.

No, it won’t, because they were fast-tracked! All they care about are profits!

He said the fast-track decision appeared more political than scientific since it skipped the usual formal advisory committee meeting and did not fully account for the reports of deaths and disabilities suffered by people after being vaccinated.

Senator Ron Johnson